We can conclude that the coincidence of the effects of HSA-MG with features of neutrophil function in type 2 diabetes is hardly accidental and probably reflects the mechanisms of pathological processes leading to premature priming and activation of neutrophils and a decrease in their bactericidal activity in diabetes. This evidence concerns the gene ALB and diabetes mellitus.